Matinas BioPharma | SC 13G:超过5%持股股东披露文件-Highbridge Capital Management, LLC(9.99%)
Matinas BioPharma | 4:持股变动声明-高管 Matkovits Theresa
Matinas BioPharma | 4:持股变动声明-高管 Hoover Thomas
Matinas BioPharma | 4:持股变动声明-首席财务官 Kucinski Keith A
Matinas BioPharma | 4:持股变动声明-首席技术官 Liu Hui
Matinas BioPharma | 4:持股变动声明-高管 Jabbour Jerome D
Matinas BioPharma | 4:持股变动声明-高管 Ferguson James J. III
Matinas BioPharma | 4:持股变动声明-董事 Ende Eric J
Matinas BioPharma | 4:持股变动声明-董事 Corzo Kathryn Penkus
Matinas BioPharma | 4:持股变动声明-董事 WIKLER MATTHEW
Matinas BioPharma | 4:持股变动声明-董事 CONRAD HERBERT J
Matinas BioPharma | 4:持股变动声明-董事 Scibetta James S
Matinas BioPharma | 4:持股变动声明-董事 Giordano Natasha
Matinas BioPharma | 4:持股变动声明
Matinas BioPharma | 4:持股变动声明
Matinas BioPharma | 4:持股变动声明
Matinas BioPharma | 4:持股变动声明
Matinas BioPharma | 4:持股变动声明
Matinas BioPharma | 4:持股变动声明
Matinas BioPharma | 4:持股变动声明